Neuphoria TherapeuticsNEUP
13F holders, Q4 2025 (December 31)21holders +6
9new positions
3sold out
$3.88avg. 13F price*
At the end of Q4 2025, 21 institutions reported holding Neuphoria Therapeutics Inc. (NEUP) in their 13F filings, up 6 from Q3 2025. 9 opened new positions and 3 sold out. The largest holders were Lynx1 Capital Management LP ($3.4M), Shay Capital LLC ($656K) and AdvisorShares Investments LLC ($521K).
- Company
- Neuphoria Therapeutics Inc.
- CUSIP
- 64136E102
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 9 | $4.7M |
| Exits | 3 | $568K |
All 13F filers, Q3 2025 → Q4 2025: 1,319,333 shares bought and 48,672 shares sold, net +1,270,661 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 21 holders
| Lynx1 Capital Management LP | 0.69% | New | 875,228 | $3.4M |
| Shay Capital LLC | 0.11% | New | 169,059 | $656K |
| AdvisorShares Investments LLC | 0.09% | Add +129.1% | 134,194 | $521K |
| Diadema Partners LP | 0.12% | Add +133.1% | 50,000 | $194K |
| Ikarian Capital, LLC | 0.02% | New | 47,443 | $184K |
| ADAR1 Capital Management, LLC | 0.01% | New | 30,000 | $116K |
| FNY Investment Advisers, LLC | 0.03% | New | 26,500 | $102K |
| Vanguard Group Inc. | 0.00% | No change | 20,950 | $81K |
| Geode Capital Management, LLC | 0.00% | Add +33.3% | 17,303 | $67K |
| Jane Street Group, LLC | 0.00% | Add +5.9% | 16,597 | $64K |
| Bridgeway Capital Management, LLC | 0.00% | New | 14,750 | $57K |
| Boothbay Fund Management, LLC | 0.00% | New | 14,000 | $54K |
| Persistent Asset Partners Ltd | 0.03% | Add +173.1% | 13,403 | $52K |
| XTX Topco Ltd | 0.00% | New | 12,008 | $47K |
| Commonwealth Equity Services, LLC | 0.00% | New | 11,207 | $43K |
| Merck & Co., Inc. | 0.01% | No change | 10,027 | $39K |
| UBS Group AG | 0.00% | Reduce -23.8% | 1,652 | $6K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +241.5% | 1,400 | $5K |
| Rhumbline Advisers | 0.00% | Add +512.1% | 202 | $783 |
| Morgan Stanley | 0.00% | Add +728.6% | 58 | $225 |
| Bank of America Corp. | 0.00% | Add +5.9% | 18 | $70 |
"% of holder's portfolio" is NEUP's weight in each manager's 13F, not the share of Neuphoria Therapeutics Inc. the manager owns.